Overview

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To assess whether a combination of ciprofloxacin and adalimumab is more effective than adalimumab alone for the treatment of perianal fistulas in Crohn's disease
Phase:
Phase 3
Details
Lead Sponsor:
Foundation for Liver Research
Treatments:
Adalimumab
Ciprofloxacin